Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
i-Cord is a specialized cord blood banking and stem cell technology company based in South Korea, operating as a key division of Boryung Bio Pharma. The company focuses on the collection, processing, and long-term cryopreservation of hematopoietic stem cells derived from umbilical cord blood for use in treating various hematologic and genetic disorders. i-Cord maintains state-of-the-art GMP-compliant facilities and has established one of the largest private cord blood repositories in the region. Beyond storage services, the company is involved in supporting clinical research into regenerative medicine and the therapeutic application of mesenchymal stem cells. Its services are integrated into the broader healthcare offerings of the Boryung Pharmaceutical Group, providing families with biological insurance against future medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on i-Cord.